|
🐜
|
Protection of the Human Gut Microbiome From Antibiotics
18 auth.
J. Gunzburg,
A. Ghozlane,
A. Ducher,
E. Le Chatelier,
X. Duval,
E. Ruppé,
L. Armand-Lefèvre,
F. Sablier-Gallis,
C. Burdet,
L. Alavoine,
...
E. Chachaty,
Violaine Augustin,
M. Varastet,
F. Levenez,
S. Kennedy,
N. Pons,
F. Mentré,
A. Andremont
|
7 |
2017 |
7
🐜
|
|
🐜
|
Targeted adsorption of molecules in the colon with the novel adsorbent‐based Medicinal Product, DAV132: A proof of concept study in healthy subjects
11 auth.
J. de Gunzburg,
A. Ducher,
C. Modess,
Danilo Wegner,
S. Oswald,
Jennifer Dressman,
...
Violaine Augustin,
C. Féger,
A. Andremont,
W. Weitschies,
W. Siegmund
|
5 |
2015 |
5
🐜
|
|
🐜
|
Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: Results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial
9 auth.
R. Phillip Dellinger,
J. Tomayko,
D. Angus,
S. Opal,
M. Cupo,
Sharon McDermott,
...
A. Ducher,
T. Calandra,
J. Cohen
|
5 |
2009 |
5
🐜
|
|
🐜
|
Microbiota-based markers predictive of development of Clostridioides difficile infection
56 auth.
M. Berkell,
Mohamed Mysara,
B. Xavier,
C. V. van Werkhoven,
Pieter Monsieurs,
C. Lammens,
A. Ducher,
M. Vehreschild,
H. Goossens,
J. de Gunzburg,
M. Bonten,
S. Malhotra-Kumar,
A. Engbers,
M. de Regt,
L. Biehl,
...
O. Cornely,
Nathalie Jazmati,
M. Bouverne,
F. Sablier-Gallis,
F. Mentré,
Uta Merle,
A. Stallmach,
J. Rupp,
J. Bogner,
C. Lübbert,
G. Silling,
O. Witzke,
A. Gikas,
S. Maraki,
G. Daikos,
S. Tsiodras,
A. Skoutelis,
H. Sambatakou,
M. Pujol,
M. A. Domínguez-Luzón,
J. Aguado,
E. Bouza,
J. Cobo,
J. Rodríguez-Baño,
B. Almirante,
J. de la Torre Cisneros,
S. Florescu,
M. Nica,
A. Vâță,
A. Hristea,
M. Lupșe,
D. Herghea,
D. Postil,
O. Barraud,
J. Molina,
V. de Lastours,
T. Guimard,
J. Talarmin,
X. Duval,
L. Bernard,
O. Launay
|
5 |
2021 |
5
🐜
|
|
🐜
|
Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics
56 auth.
C. V. van Werkhoven,
A. Ducher,
M. Berkell,
Mohamed Mysara,
C. Lammens,
J. Torre-Cisneros,
J. Rodríguez-Baño,
D. Herghea,
O. Cornely,
L. Biehl,
L. Bernard,
M. Dominguez-Luzon,
S. Maraki,
O. Barraud,
M. Nica,
...
Nathalie Jazmati,
F. Sablier-Gallis,
J. de Gunzburg,
F. Mentré,
S. Malhotra-Kumar,
M. Bonten,
M. Vehreschild,
Annemarie M. S. Engbers,
M. de Regt,
H. Goossens,
B. Xavier,
M. Bouverne,
Pieter Monsieurs,
Uta Merle,
A. Stallmach,
J. Rupp,
J. Bogner,
C. Lübbert,
G. Silling,
O. Witzke,
A. Gikas,
G. Daikos,
S. Tsiodras,
A. Skoutelis,
H. Sambatakou,
M. Pujol,
J. Aguado,
E. Bouza,
J. Cobo,
B. Almirante,
S. Florescu,
A. Vâță,
A. Hristea,
M. Lupșe,
D. Postil,
J. Molina,
V. de Lastours,
T. Guimard,
J. Talarmin,
X. Duval,
O. Launay
|
4 |
2021 |
4
🐜
|
|
🐜
|
Modeling the Effect of DAV132, a Novel Colon‐Targeted Adsorbent, on Fecal Concentrations of Moxifloxacin and Gut Microbiota Diversity in Healthy Volunteers
7 auth.
Jinju Guk,
J. Guedj,
C. Burdet,
A. Andremont,
J. Gunzburg,
A. Ducher,
...
F. Mentré
|
3 |
2020 |
3
🐜
|
|
🐜
|
High acquisition rate of extended-spectrum β-lactamase-producing Enterobacteriaceae among French military personnel on mission abroad, without evidence of inter-individual transmission.
14 auth.
N. Maataoui,
A. Mayet,
S. Duron,
H. Delacour,
F. Mentré,
C. Laouénan,
D. Desvillechabrol,
T. Cokelaer,
J. Meynard,
J. Meynard,
...
A. Ducher,
A. Andremont,
L. Armand-Lefèvre,
A. Mérens
|
3 |
2019 |
3
🐜
|
|
🐜
|
An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones
12 auth.
M. Vehreschild,
A. Ducher,
T. Louie,
O. Cornely,
C. Féger,
A. Dane,
...
M. Varastet,
F. Vitry,
J. de Gunzburg,
A. Andremont,
F. Mentré,
M. Wilcox
|
3 |
2022 |
3
🐜
|
